Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Marc Odrich

LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Marc Odrich was appointed Chief Medical Officer, effective March 21, 2024. The proxy statement of LENZ Therapeutics, Inc. reports total compensation of $2,436,788 for Marc Odrich in fiscal 2025, including a base salary of $500,000. Disclosed compensation is on record for 3 fiscal years. Marc Odrich has spoken on 1 earnings call across 1 company, most recently for LENZ Therapeutics, Inc. on May 7, 2025.

“On March 21, 2024, the following individuals were appointed to serve as executive officers of New LENZ: | Marc Odrich, M.D. | Chief Medical Officer”
LENZ Therapeutics, Inc. Form 8-K, filed March 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at LENZ Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 LENZ Therapeutics, Inc. (LENZ) $500,000 $2,436,788
2024 LENZ Therapeutics, Inc. (LENZ) $466,250 $2,039,143
2023 LENZ Therapeutics, Inc. (LENZ) $410,000 $920,163

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.